Morepen Laboratories Ltd.
Snapshot View

View in App

Prices View details >>

25.68 -0.12 ▼-0.5%

31 March 2023, 04:01:00 PM
Volume: 917,312

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.morepen.com
Market Cap 1,312.68 Cr.
Enterprise Value(EV) 1,294.84 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.84 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 30.70 Trailing Twelve Months Ending 2022-12
Industry PE 32.41 Trailing Twelve Months Ending 2022-12
Book Value / Share 14.23 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.80 Calculated using Price: 25.68
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 51.12 Cr. 511,168,708 Shares
FaceValue 2
Company Profile
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.47%
1 Week
+5.12%
1 Month
+1.10%
3 Month
-32.06%
6 Month
+7.45%
1 Year
-29.84%
2 Year
-20.12%
5 Year
-16.76%
10 Year
+923.11%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -1.54 1.24 7.35 12.54 14.10 12.04 12.50 29.20 21.79
Return on Capital Employed (%) 1.80 2.90 6.29 10.18 14.05 10.01 12.05 27.13 24.86
Return on Assets (%) -0.55 0.44 2.53 4.45 5.30 4.80 5.25 12.76 10.55

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 297 287 300 196 226 253 284 425 579 737
Non Curr. Liab. 85 74 57 18 20 23 28 30 36 35
Curr. Liab. 108 128 167 325 340 339 351 404 456 280
Minority Int. 0 0 -1 -1 0 0 0 0 0 0
Equity & Liab. 490 489 524 538 586 615 663 858 1,070 1,052
Non Curr. Assets 393 374 367 346 342 316 291 331 336 351
Curr. Assets 96 115 157 192 243 299 372 527 734 701
Misc. Exp. not W/O
Total Assets 490 489 524 538 586 615 663 858 1,070 1,052

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 367 401 485 595 607 769 853 1,188 1,547 1,422
Other Income 1 1 1 4 4 4 9 12 20 6
Total Income 368 402 486 599 610 772 863 1,200 1,567 1,428
Total Expenditure -318 -352 -424 -534 -542 -701 -785 -1,070 -1,410 -1,339
PBIDT 50 50 63 65 68 71 78 131 157 89
Interest -10 -9 -11 -8 -4 -2 -2 -2 -2 -2
Depreciation -46 -39 -35 -34 -34 -40 -37 -30 -28 -28
Taxation 0 0 0 0 -6 -1 -25 -16
Exceptional Items 3 -4
PAT -3 2 13 24 30 29 34 97 102 43
Minority Interest 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit -3 2 13 24 30 29 34 97 102 43
Adjusted EPS 0 0 0 1 1 1 1 2 2 1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 34 51 50 41 63 17 11 51 -58
Cash Fr. Inv. -3 -1 -32 -27 -14 -27 -13 -12 -70 -32
Cash Fr. Finan. -30 -29 -19 -27 -24 -38 0 5 47 64
Net Change 1 4 0 -4 3 -1 4 4 28 -26
Cash & Cash Eqvt 6 9 9 4 7 6 10 14 41 16

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 34.54 34.54 34.54 34.54 34.54 38.38 36.74 38.22 38.22
Public 65.46 65.46 65.46 65.46 65.46 61.62 63.26 61.78 61.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 31 Mar 2023
Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 as amended and in accordance with the Code of Conduct to Regulate Monitor and Report of Trading by Insiders for trading in Companys Shares/ Securities the Trading Window will remain closed with effect from April 01 2023 for the purpose of consideration and approval of audited financial results for the quarter and financial year ended March 31 2023.During the aforesaid closed trading window period the Designated Persons shall not trade in Companys shares/ securities.The Trading Window shall remain closed till 48 hours after the announcement of the said financial results when the information becomes generally available.
Tue, 28 Mar 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to the Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended please find attached herewith letters dated 28th March 2023 received from Registrar and Share Transfer Agent of the company (viz. MAS Services Limited) regarding loss of share certificates of the company. In terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR /2022/8 dated 25th January 2022 the company shall issue Letter of Confirmation to the concerned shareholder after compliance of requisite formalities.
Sat, 25 Mar 2023
Successful Completion Of USFDA Inspection Of API Facility At Baddi (H.P.)
This is to inform you that the United States Food and Drug Administration (USFDA) conducted an inspection of the API manufacturing facility at Baddi Himachal Pradesh of the company.The facility has been cleared by USFDA on 24th March 2023 without any adverse observation (NIL 483).

Technical Scans View Details >>

Fri, 31 Mar 2023
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 3 Months High Decrease in 3 Months
Closing Near 20 SMA Closing Near 20 SMA
Doji and Near Doji Doji and Near Doji
Wed, 29 Mar 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,878.62 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. 76,960.86 4,624.15 +1.3%
Divi's Laboratories Ltd. 75,014.78 2,826.00 +0.3%
Cipla Ltd. 72,696.02 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. 61,962.56 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. 52,030.91 1,543.40 +0.2%
Zydus Lifesciences Ltd. 49,749.83 491.00 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.00 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 21.13 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.30 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 27.55 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.03 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.86 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.11 491.00 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.26 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-12 6.03 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-12 3.20 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.19 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.88 491.00 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 491.00 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 491.00 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 491.00 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.10 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,624.15 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.00 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 900.65 +1.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,309.40 -1.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,543.40 +0.2%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 491.00 +0.1%

FAQ's On Morepen Laboratories Ltd.

What is Morepen Laboratories share price?
Can I buy Morepen Laboratories shares now?
What is the Market Cap of Morepen Laboratories?
What are the key metrics to analyse Morepen Laboratories?
What is the 52 Week High and Low of Morepen Laboratories?
What is the trend of Morepen Laboratories share price?